FDA Inspection 890539 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 1071676

The FDA completed an inspection of Octapharma Plasma, Inc. on August 6, 2014 in Charlotte, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 6, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Charlotte, NC (United States)

Citations

IDCFRDescription
15521 CFR 606.160(b)Required records